TGF-β1 and radiation fibrosis: A master switch and a specific therapeutic target?

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 2, 2000, Pages 277-290

  Martin, Michèle ^a   Lefaix, Jean Louis ^a   Delanian, Sylvie ^b  

^a CEA SACLAY   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Fibrosis; Ionizing radiation; Myofibroblast; TGF 1; Treatment

Indexed keywords

ANTIFIBROTIC AGENT; TRANSFORMING GROWTH FACTOR BETA1; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL ACTIVATION; FIBROSIS; HUMAN; IONIZING RADIATION; MYOFIBROBLAST; PRIORITY JOURNAL; RADIATION INJURY; SIGNAL TRANSDUCTION; TISSUE REPAIR; ANIMAL; APOPTOSIS; CELL CULTURE; CELL DIVISION; CELLULAR IMMUNITY; DRUG COMBINATION; FIBROBLAST; INTESTINE; LUNG; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; RADIATION DERMATITIS; RADIATION EXPOSURE; REVIEW; SKIN; SWINE;

ANIMALS; APOPTOSIS; CELL DIVISION; CELLS, CULTURED; DRUG THERAPY, COMBINATION; FIBROBLASTS; FIBROSIS; HUMANS; IMMUNITY, CELLULAR; INTESTINES; LUNG; MICE; RADIATION INJURIES; RADIODERMATITIS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SKIN; SWINE; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034178260     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00435-1     Document Type: Article

References (120)

1. Roberts AB, Sporn MB. The transforming growth factor-βs. In: Sporn MB. Roberts AB, editors. Peptide growth factors and their receptors. Vol. 1. Berlin: Springer-Verlag; 1990. p. 419-472.
2. Massagué J. The transforming growth factor-β family. Annu Rev Cell Biol. 6:1990;597-641.
3. Lawrence D. Transforming growth factor-β A general review . Eur Cytokine Netw. 7:1996;363-374.
4. Letterio J.J., Böttinger E.P. TGF-β knockout and dominant-negative receptor transgenic mice. Miner Electrolyte Metab. 24:1998;161-167.
5. Roberts A.B., Anzano M.A., Lamb L.C., et al. New class of TGF-βs potentiated by epidermal growth factor Isolation from non-neoplastic tissues . Proc Natl Acad Sci USA. 78:1981;5339-5343.
6. Moses H.L., Branum E.L., Proper J.A., et al. TGF-β production by chemically transformed cells. Cancer Res. 41:1981;2842-2848.
7. Assoian K., Komoriya A., Meyers C.A., et al. TGF-β in human platelets. J Biol Chem. 258:1983;7155-7160.
8. Derynck R., Jarrett J.A., Chen E.Y., et al. Human TGF-β cDNA sequence and expression in human tumor lines. Nature. 316:1985;701-705.
9. Pircher R., Jullien P., Lawrence D.A. β-Transforming growth factor is stored in human platelets as a latent high molecular weight complex. Biochem Biophys Res Commun. 136:1986;30-37.
10. Saharinen J., Hyytiäinen M., Taipale J., et al. LTBPs structural extracellular matrix proteins for targeting TGF-β action. Cyt Growth Factor Rev. 10:1999;99-117.
11. Saltis J. TGF-β Receptors and cell cycle arrest . Mol Cell Endocrinol. 116:1996;227-232.
12. Derynck R., Feng X.H. TGF-β receptor signaling. Biochem Biophys Acta. 1333:1997;105-150.
13. Zhang Y., Geng X.H., Wu R.Y., et al. Receptor-associated MAD homologues synergize as effectors of the TGF-β response. Nature. 383:1996;832-836.
14. Kretzschmar M., Massague J. Smads Mediators and regulators of TGF-β signaling . Current Op Genet Develop. 8:1998;103-111.
15. Sporn M.B. The importance of context in cytokine action. Kidney Int. 51:1997;1352-1354.
16. Koff A., Ohtsuki M., Polyak K., et al. Negative regulation of G1 in mammalian cells Inhibition of cyclin E-dependent kinase by TGF-β Science. 260:1993;536-539.
17. Datto M.B., Li Y., Panus J.F., et al. TGF-β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA. 92:1995;5545-5549.
18. Hannon G.J., Beach D. p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature. 371:1994;257-261.
19. Oberhammer F.A., Palvelka M., Sharma S., et al. Induction of apoptosis in cultured hepatocytes and in regressing liver by TGF-β1. Proc Natl Acad Sci USA. 89:1992;5408-5412.
20. Rotello R.J., Lieberman R.C., Purchio A.F., et al. Coordinated regulation of apoptosis and cell proliferation by TGF-β1 in cultured uterine epithelial cells. Proc Natl Acad Sci USA. 88:1991;3412-3415.
21. Benassi L., Ottani D., Fantini F., et al. 1,25-dihydroxyvitamin D3, TGF-β1, calcium, and UV B radiation induce apoptosis in cultured human keratinocytes. J Invest Dermatol. 109:1997;276-282.
22. Tang B., Böttinger E., Jakowlew S.B., et al. TGF-β1 is a new form of tumor suppressor with true haploid insufficiency. Nature Med. 4:1998;802-807.
23. Amendt C., Schirmacher P., Blessing M. Expression of a dominant negative type II TGF-β receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development. Oncogene. 17:1998;25-34.
24. Akiyama Y., Iwanaga R., Ishikawa T., et al. Mutations of the TGF-β type II receptor gene are strongly related to sporadic proximal colon carcinomas with microsatellite instability. Cancer. 78:1996;2478-2484.
25. Togo G., Toda N., Kanai F., et al. A TGF-β type II receptor gene mutation common in sporadic cecum cancer with microsatellite instability. Cancer Res. 56:1996;5620-5623.
26. Hahn S.A., Schutte M., Hoque A.T., et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science. 271:1996;350-353.
27. Eppert K., Scherer S.W., Ozcelik H., et al. MADR2 maps to 18q21 and encodes a TGF-β-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell. 86:1996;543-552.
28. Raynal S., Lawrence D.A. Differential effects of TGF-β1 on protein levels of p21 WAF and cdk-2 kinase activity in human RD and CCL64 mink lung cells. Int J Oncol. 7:1995;337-341.
29. Ravitz M.J., Yan S., Dolce C., et al. Differential regulation of p27 and cyclin D1 by TGF-β and EGF in C3H 10T1/2 mouse fibroblasts. J Cell Physiol. 168:1996;510-520.
30. Vodovotz Y., Bogdan C., Paik J., et al. Mechanisms of suppression of macrophage nitric oxide release by TGF-β J Exp Med. 178:1993;605-6013.
31. Border W.A., Noble N.A. Transforming growth factor-beta in tissue fibrosis. N Engl J Med. 10:1994;1286-1292.
32. Roberts A.B., Sporn M.B., Assoian R.K., et al. TGF-β Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro . Proc Natl Acad Sci USA. 83:1986;4167-4171.
33. Terrel T.G., Working P.K., Chow C.P., et al. Pathology of human recombinant TGF-β in rats and rabbits. Int Rev Exp Pathol. 34:1993;43-67.
34. Zugmaier G., Paik S., Wilding G., et al. TGF-β 1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. Cancer Res. 51:1991;3590-3594.
35. Sanderson N., Factor V., Nagy P., et al. Hepatic expression of mature TGF-β1 in transgenic mice results in multiple lesions. Proc Natl Acad Sci USA. 92:1995;2572-2576.
36. Clouthier D.E., Comerford S.A., Hammer R.E. Hepatic fibrosis, glomerulosclerosis and a lipodystrophy-like syndrome in PEPCK-TGF-β1 transgenic mice. J Clin Invest. 100:1997;2697-2713.
37. Bentzen S.M., Thames H.D., Overgaard M. Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study. Radiother Oncol. 15:1989;267-274.
38. Lefaix J.L., Daburon F. Diagnosis of acute localized irradiation lesions A review of the French experimental experience . Health Physics. 75:1998;375-384.
39. McDonald S., Rubin P., Phillips T.C., et al. Injury to the lung from cancer therapy Clinical syndromes, measurable endpoints, and potential scoring systems . Int J Radiat Oncol Biol Phys. 31:1995;1187-1203.
40. Fajardo L.F., Stewart J.R. Pathogenesis of radiation induced myocardial fibrosis. Lab Invest. 29:1973;244-257.
41. Geraci J.P., Mariano M.S. Radiation hepatology of the rat Parenchymal and nonparenchymal cell injury . Radiat Res. 136:1993;205-213.
42. Rodeman H.P., Bamberg M. Cellular basis of radiation-induced fibrosis. Radiother Oncol. 35:1995;83-90.
43. Rubin P., Johnston C., Williams J., et al. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys. 33:1995;99-109.
44. Barcellos-Hoff M.H. How do tissues respond to damage at the cellular level? The role of cytokines in irradiated tissues. Radiat Res. 150:(Suppl.):1998;S109-S120.
45. Skwarchuk M.W., Travis E.L. Changes in histology and fibrogenic cytokines in irradiated colorectum of two murine strains. Int J Radiat Oncol Biol Phys. 42:1998;169-178.
46. Gabbiani G. Modulation of fibroblastic cytoskeletal features during wound healing and fibrosis. Path Res Prac. 190:1994;851-853.
47. Desmoulière A. Factors influencing myofibroblast differentiation during wound healing and fibrosis. Cell Biol Int. 19:1996;471-476.
48. Powell D.W., Mifflin R.C., Valentich J.D., et al. Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol. 277:1999;C1-C9.
49. Desmoulière A., Redard M., Darby I., et al. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol. 146:1995;56-66.
50. Moulin V. Growth factors in skin wound healing. Eur J Cell Biol. 68:1995;1-7.
51. Trojanowska M., Carwile Leroy E., Eckes B., et al. Pathogenesis of fibrosis Type 1 collagen and the skin . J Mol Med. 76:1998;266-274.
52. Hopewell J.W. The skin Its structure and response to ionizing radiation . Int J Radiat Biol. 57:1990;751-773.
53. Trott KR, Kummermehr J. Radiation effects in skin. In: Schere E, Streffer C, Trott KR, editors. Radiopathology of organs and tissues. Berlin: Springer-Verlag; 1991. p. 33-66.
54. Archambeau J.O., Pezner R., Wasserman T. Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys. 31:1995;1171-1185.
55. Martin M., Vozenin M.C., Gault N., et al. Coactivation of AP-1 activity and TGF-β1 gene expression in the stress response of normal skin cells to ionizing radiation. Oncogene. 15:1997;8, 981-8, 989.
56. Randall K., Coggle J. Expression of TGF-β1 in mouse skin during the acute phase of radiation damage. Int J Radiat Biol. 68:1995;301-309.
57. Langberg C.W., Hauer-Jensen M., Sung C.C., et al. Expression of fibrogenic cytokines in rat small intestine after fractionated irradiation. Radiother Oncol. 32:1994;29-36.
58. Barcellos-Hoff M.H. Radiation-induced TGF-β and subsequent extracellular matrix reorganization in murine mammary gland. Cancer Res. 53:1993;3880-3886.
59. Barcellos-Hoff M.H., Derynck R., Tsang M.L.S., et al. Transforming growth factor-β activation in irradiated murine mammary gland. J Clin Invest. 93:1994;892-899.
60. Ehrhart E.J., Segarini P., Tsang M., et al. Latent TGF-β1 activation in situ Quantitative and functional evidence after low-dose gamma-irradiation . FASEB J. 11:1997;991-1002.
61. Chang C.M., Limanni A., Baker W.H., et al. Bone marrow and splenic granulocyte-macrophage colony-stimulating factor and transforming growth factor-beta mRNA levels in irradiated mice. Blood. 86:1995;2130-2136.
62. Finkelstein J.N., Johnston C., Baggs R., et al. Early alterations in extracellular matrix and transforming growth factor β gene expression in mouse lung indicative of late radiation fibrosis. Int J Radiat Oncol Biol Phys. 28:1994;621-631.
63. Ruifrok A.C., Mason K.A., Lozano G., et al. Spatial and temporal patterns of expression of EGF, TGF-α and TGF-β 1-3 and their receptors in mouse jejunum after radiation treatment. Radiat Res. 147:1997;1-12.
64. Clave E., Carosella M.D., Gluckman E., et al. Ionizing radiation effects on the KG1 primitive hematopoietic cell line. Int J Radiat Oncol Biol Phys. 35:1996;709-719.
65. Bentzen SM, Overgaard M. Normal tissue morbidity after breast cancer treatment. In: Altman KI, Lett JT, editors. Advances in radiation biology. Orlando, FL: Academic Press; 1994. p. 25-51.
66. Ricks RC, Fry SA. The medical basis for radiation accident preparedness II. Amsterdam: Elsevier; 1990.
67. Peter R.U., Braun-Falco O., Birioukov A., et al. Chronic cutaneous damage after accidental exposure to ionizing radiation The Chernobyl experience . J Am Acad Dermatol. 30:1994;719-723.
68. Peter R.U. Cutaneous radiation syndromes Clinical and therapeutical aspects . Radiol Prot Bul. 183:1996;19-25.
69. Lefaix J.L., Martin M., Tricaud Y., et al. Muscular fibrosis induced after pig skin irradiation with single doses of 192 Ir γ-rays. Br J Radiol. 66:1993;537-544.
70. Martin M., Lefaix J.L., Crechet F., et al. Temporal modulation of TGF-β1 gene expression in pig skin and muscular fibrosis after ionizing radiation. Radiat Res. 134:1993;63-70.
71. Delanian S., Martin M., Bravard A., et al. Abnormal phenotype of human cultured fibroblasts from cutaneous fibrosis induced by therapeutic irradiation. Radiother Oncol. 3:1998;255-261.
72. Vozenin-Brotons M.C., Gault N., Sivan V., et al. Histopathological and cellular studies of a case of accidental cutaneous radiation syndrome after chronic exposure to cesium sources. Radiat Res. 152:1999;332-337.
73. Delanian S., Martin M., Lefaix J.L. TGFb1, collagen I and III gene expression in human skin fibrosis induced by therapeutic irradiation. Br J Radiol. 65:1992;82-83.
74. Martin M., Rémy J., Daburon F. Abnormal proliferation and aging of cultured fibroblasts from pigs with subcutaneous fibrosis induced by γ-irradiation. J Invest Dermatol. 93:1989;497-500.
75. Rodeman H.P., Peterson H.P., Schwenke K. Terminal differentiation of human fibroblasts is induced by radiation. Scan Microsc. 5:1991;1135-1143.
76. Delanian S., Baillet F., Huart J., et al. Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase Clinical trial . Radiother Oncol. 32:1994;12-20.
77. Benyahia B., Magdelenat H. Immunohistochemical characterization of human γ-irradiated skin. Bull Cancer/Radiother. 80:1993;126-134.
78. Randall K., Coggle J.E. Long-term expression of transforming growth factor TGFβ1 in mouse skin after localized β-irradiation. Int J Radiat Biol. 70:1996;351-360.
79. Canney P.A., Dean S. TGF-β A promoter of late connective tissue injury following radiotherapy? Br J Radiol. 63:1990;620-623.
80. Anscher M.S., Kong F.-M., Andrews K., et al. Plasma TGF-β1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys. 41:1998;1029-1035.
81. Rubin I., Finkelstein J., Shapiro D. Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes Interrelationship between the alveolar macrophage and the septal fibroblast . Int J Radiat Oncol Biol Phys. 24:1992;93-101.
82. Yi E.S., Bedoya A., Lee H., et al. Radiation-induced lung injury in vivo Expression of transforming growth factor-beta precedes fibrosis . Inflammation. 20:1996;339-351.
83. Franko A.J., Sharplin J., Ghahary A., et al. Immunohistochemical localization of TGF-β and TNF-α in the lungs of fibrosis-prone and "non-fibrosing" mice during the latent period and early phase after irradiation. Radiat Res. 147:1997;245-256.
84. Vujaskovic Z., Down J.D., van Waarde M.A., et al. Plasma TGF-β level in rats after hemithoracic irradiation. Radiother Oncol. 44:1997;41-43.
85. Richter K., Langberg C., Sung C.C., et al. Association of TGF-β immunoreactivity with specific histopathologic lesions in subacute and chronic experimental radiation enteropathy. Radiother Oncol. 39:1996;243-251.
86. Hauer-Jensen M., Richter K., Wang J., et al. Changes in TGF-β1 gene expression and immunoreactivity levels during development of chronic radiation enteropathy. Radiat Res. 50:1998;673-680.
87. Anscher M.S., Crocker I.R., Jirtle R.L. Transforming growth factor-β1 expression in irradiated liver. Radiat Res. 122:1990;77-85.
88. Kraft M., Oussoren Y., Stewart F.A., et al. Radiation-induced changes in TGF-β and collagen expression in the murine bladder wall and its correlation with bladder function. Radiat Res. 146:1996;619-627.
89. Wahl S.M. TGF-β in inflammation A cause and a cure . J Clin Immunol. 12:1992;61-74.
90. Johnston C.J., Piedboeuf B., Rubin P., et al. Early and persistent alterations in the expression of Il-1α, IL-1β and TNF-α mRNA levels in fibrosis-resistant and sensitive mice after thoracic irradiation. Radiat Res. 145:1996;762-767.
91. Grotendorst G.R., Okochi H., Hayashi N. A novel TGF-β response element controls the expression of the connective tissue growth factor gene. Cell Growth Different. 7:1996;469-480.
92. Dubrawsky C., Dubrawsky N.B., Withers H.R. The effect of colchicine on the accumulation of hydroxyproline and on lung compliance after irradiation. Radiat Res. 73:1978;111-120.
93. Grossman H.J., White D., Grossman V.L., et al. Effect of interferon-α on intrahepatic haemodynamics of the cirrhotic rat liver. J Gastroenterol Hepatol. 13:1998;1058-1060.
94. Calès P. Apoptosis and liver fibrosis Antifibrotic strategies . Biomed Pharmacother. 52:1998;259-263.
95. Peter R.U., Gottlöber P., Nadeshina G.K., et al. Interferon gamma in survivors of the Tchernobyl power plant accident New therapeutic option for radiation-induced fibrosis . Int J Radiat Oncol Biol Phys. 45:1999;147-152.
96. Moreno M., Muriel P. Remission of liver fibrosis by interferon α-2b. Biochem Pharmacol. 4:1995;515-520.
97. Tredget E.E., Heather A., Shankowsky R.N., et al. TGF-β in thermally injured patients with hypertrophic scars Effects of interferon α-2b . Plast Reconstr Surg. 102:1998;1317-1328.
98. Dufour J.F., DeLellis R., Kaplan M.M. Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment. Dig Dis Sci. 43:1998;2573-2576.
99. Cutroneo K.R., Rokowski R., Counts D.F. Glucocorticoids and collagen synthesis Comparison of in vivo and cell culture studies . Collagen Rel Res. 1:1981;557-568.
100. Hopewell J.W., van den Aardweg G.J., Morris G.M., et al. Amelioration of both early and late radiation-induced damage to pig skin by essential fatty acids. Int J Radiat Oncol Biol Phys. 30:1994;1119-1125.
101. Benyaha B., Campana F., Perdereau B., et al. Effects of superoxide dismutase topical treatment on human skin radiofibrosis A pathological study . Breast. 5:1996;75-81.
102. Lefaix J.L., Delanian S., Leplat J.J., et al. Successful treatment of radiation-induced fibrosis using Cu/Zn-SOD and Mn-SOD An experimental study . Int J Radiat Oncol Biol Phys. 35:1996;305-312.
103. Werner-Wasik M., Madoc-Jones H. Trental (pentoxifylline) relieves pain from post-radiation fibrosis. Int J Radiat Oncol Biol Phys. 25:1993;757-758.
104. Lefaix J.L., Delanian S., Vozenin M.C., et al. Striking regression of subcutaneous fibrosis induced by high doses of γ-rays using a combination of pentoxifylline and alpha-tocopherol An experimental study . Int J Radiat Oncol Biol Phys. 43:1999;839-847.
105. Baillet F. Alpha-tocopherol treatment of radiofibrosis post-brachytherapy for breast cancer (Abstr). Radiother Oncol 1997;43(Suppl.):S3.
106. Delanian S., Balla-Mekias S., Lefaix J.L. Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and a tocopherol. J Clin Oncol. 17:1999;3283-3290.
107. Piguet P.F., Rosen H., Vesin C., et al. Effective treatment of the pulmonary fibrosis elicited in mice by bleomycin or silica with anti-CD-11 antibodies. Am Rev Respir Dis. 147:1993;435-441.
108. Piguet P.F., Vesin C. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur Respir J. 7:1994;515-518.
109. Dion M.W., Hussey D.H., Doornbos J.F., et al. Preliminary results of a pilot study of pentoxifylline in the treatment of late radiation soft tissue necrosis. Int J Radiat Oncol Biol Phys. 19:1990;401-407.
110. Futran N.D., Trotti A., Gwede C. Pentoxifylline in the treatment of radiation-related soft tissue injury Preliminary observations . Laryngoscope. 107:1997;391-395.
111. Poli G., Parola M. Oxidative damage and fibrogenesis. Free Radic Biol Med. 22:1997;287-305.
112. Border W.A., Okuda S., Languino L.R., et al. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor-beta 1. Nature. 346:1990;371-374.
113. Shah M., Forman D.M., Ferguson M.W. Control of scarring in adult wounds by neutralizing antibody to TGF-β Lancet. 339:1992;213-214.
114. Wolf Y.G., Rasmussen L.M., Ruoslahti E. Antibodies against TGF-β1 suppress intimal hyperplasia in a rat model. J Clin Invest. 93:1994;1172-1178.
115. Giri S.N., Hyde D.M., Hollinger M.A. Effect of antibody to TGF-β on bleomycin induced accumulation of lung collagen in mice. Thorax. 48:1993;959-966.
116. Choi B.M., Kwak H.J., Jun C.D., et al. Control of scarring in adults' wounds using antisense TGF-β1 oligodeoxynucleotides. Immunol Cell Biol. 74:1996;144-150.
117. Bottinger E.P., Factor V.M., Tsang M.L., et al. The recombinant proregion of TGF-β1 (latency-associated peptide) inhibits active TGF-β1 in transgenic mice. Proc Natl Acad Sci USA. 93:1996;5877-5882.
118. Oursler M.J., Riggs B.L., Spelsberg T.C. Glucocorticoid-induced activation of latent TGF-β by normal human osteoblast-like cells. Endocrinology. 133:1993;2187-2196.
119. Ulloa L., Doody J., Massagué J. Inhibition of transforming growth factor-β/Smad signaling by the interferon-γ/STAT pathway. Nature. 397:1999;710-713.
120. Martin M., Pinton P., Crechet F., et al. Preferential induction of c-fos versus c-jun proto-oncogene during the immediate early response of pig skin to γ-rays. Cancer Res. 53:1993;1-4.